Logo image of LFMDP

LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) Stock Fundamental Analysis

NASDAQ:LFMDP - Nasdaq - US53216B2034 - Currency: USD

24.17  -0.03 (-0.14%)

Fundamental Rating

4

Taking everything into account, LFMDP scores 4 out of 10 in our fundamental rating. LFMDP was compared to 36 industry peers in the Health Care Technology industry. LFMDP has a bad profitability rating. Also its financial health evaluation is rather negative. LFMDP is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

LFMDP had negative earnings in the past year.
LFMDP had a positive operating cash flow in the past year.
In the past 5 years LFMDP always reported negative net income.
In multiple years LFMDP reported negative operating cash flow during the last 5 years.
LFMDP Yearly Net Income VS EBIT VS OCF VS FCFLFMDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of LFMDP (-18.79%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -18.79%
ROE N/A
ROIC N/A
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMDP Yearly ROA, ROE, ROICLFMDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

Looking at the Gross Margin, with a value of 87.99%, LFMDP belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
LFMDP's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for LFMDP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
LFMDP Yearly Profit, Operating, Gross MarginsLFMDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

LFMDP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LFMDP has been increased compared to 1 year ago.
LFMDP has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LFMDP has been reduced compared to a year ago.
LFMDP Yearly Shares OutstandingLFMDP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LFMDP Yearly Total Debt VS Total AssetsLFMDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 6.88 indicates that LFMDP is not in any danger for bankruptcy at the moment.
The Altman-Z score of LFMDP (6.88) is better than 86.11% of its industry peers.
The Debt to FCF ratio of LFMDP is 5.81, which is a neutral value as it means it would take LFMDP, 5.81 years of fcf income to pay off all of its debts.
LFMDP has a better Debt to FCF ratio (5.81) than 63.89% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.81
Altman-Z 6.88
ROIC/WACCN/A
WACC10.2%
LFMDP Yearly LT Debt VS Equity VS FCFLFMDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 0.82 indicates that LFMDP may have some problems paying its short term obligations.
LFMDP has a Current ratio of 0.82. This is amonst the worse of the industry: LFMDP underperforms 83.33% of its industry peers.
LFMDP has a Quick Ratio of 0.82. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
LFMDP's Quick ratio of 0.77 is on the low side compared to the rest of the industry. LFMDP is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.77
LFMDP Yearly Current Assets VS Current LiabilitesLFMDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.05% over the past year.
LFMDP shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.07%.
Measured over the past years, LFMDP shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%

3.2 Future

The Earnings Per Share is expected to grow by 41.78% on average over the next years. This is a very strong growth
Based on estimates for the next years, LFMDP will show a very strong growth in Revenue. The Revenue will grow by 26.03% on average per year.
EPS Next Y103.4%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
EPS Next 5YN/A
Revenue Next Year31.46%
Revenue Next 2Y24.57%
Revenue Next 3Y26.03%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LFMDP Yearly Revenue VS EstimatesLFMDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
LFMDP Yearly EPS VS EstimatesLFMDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

3

4. Valuation

4.1 Price/Earnings Ratio

LFMDP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 73.48, LFMDP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LFMDP is on the same level as its industry peers.
LFMDP's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.60.
Industry RankSector Rank
PE N/A
Fwd PE 73.48
LFMDP Price Earnings VS Forward Price EarningsLFMDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

LFMDP's Enterprise Value to EBITDA ratio is in line with the industry average.
LFMDP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 346.56
EV/EBITDA 414
LFMDP Per share dataLFMDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LFMDP's earnings are expected to grow with 41.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.53%
EPS Next 3Y41.78%

4

5. Dividend

5.1 Amount

LFMDP has a Yearly Dividend Yield of 9.17%, which is a nice return.
LFMDP's Dividend Yield is rather good when compared to the industry average which is at 35.16. LFMDP pays more dividend than 97.22% of the companies in the same industry.
LFMDP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 9.17%

5.2 History

LFMDP has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
LFMDP Yearly Dividends per shareLFMDP Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

LFMDP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-22.45%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
LFMDP Yearly Income VS Free CF VS DividendLFMDP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

LIFEMD INC - LFMD 8 7/8 PERP

NASDAQ:LFMDP (6/30/2025, 8:27:17 PM)

24.17

-0.03 (-0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners37.39%
Inst Owner ChangeN/A
Ins Owners17.86%
Ins Owner ChangeN/A
Market Cap1.10B
Analysts81.33
Price Target21.34 (-11.71%)
Short Float %0%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 9.17%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-22.45%
Div Incr Years0
Div Non Decr Years1
Ex-Date04-04 2025-04-04 (0.5546875)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.21%
Min EPS beat(2)61.87%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)28.94%
Min EPS beat(4)-49.02%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-4.25%
EPS beat(12)5
Avg EPS beat(12)-13.27%
EPS beat(16)6
Avg EPS beat(16)-14.35%
Revenue beat(2)2
Avg Revenue beat(2)6.37%
Min Revenue beat(2)2.97%
Max Revenue beat(2)9.78%
Revenue beat(4)3
Avg Revenue beat(4)3.24%
Min Revenue beat(4)-2.71%
Max Revenue beat(4)9.78%
Revenue beat(8)6
Avg Revenue beat(8)2.84%
Revenue beat(12)7
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.97%
PT rev (1m)-46.77%
PT rev (3m)-57.01%
EPS NQ rev (1m)33.33%
EPS NQ rev (3m)70.52%
EPS NY rev (1m)169.23%
EPS NY rev (3m)132.31%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)5.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 73.48
P/S 4.69
P/FCF 346.56
P/OCF 71.43
P/B N/A
P/tB N/A
EV/EBITDA 414
EPS(TTM)-0.34
EYN/A
EPS(NY)0.33
Fwd EY1.36%
FCF(TTM)0.07
FCFY0.29%
OCF(TTM)0.34
OCFY1.4%
SpS5.15
BVpS-0.05
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.79%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.99%
FCFM 1.35%
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.18
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.81
Debt/EBITDA 2.6
Cap/Depr 121.5%
Cap/Sales 5.22%
Interest Coverage N/A
Cash Conversion 587.29%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.77
Altman-Z 6.88
F-Score5
WACC10.2%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
EPS Next Y103.4%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
EPS Next 5YN/A
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%
Revenue Next Year31.46%
Revenue Next 2Y24.57%
Revenue Next 3Y26.03%
Revenue Next 5YN/A
EBIT growth 1Y58.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year274.77%
EBIT Next 3Y72.64%
EBIT Next 5YN/A
FCF growth 1Y112.29%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y188.08%
OCF growth 3YN/A
OCF growth 5Y133.93%